These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15587934)

  • 1. AlbuBNP, a recombinant B-type natriuretic peptide and human serum albumin fusion hormone, as a long-term therapy of congestive heart failure.
    Wang W; Ou Y; Shi Y
    Pharm Res; 2004 Nov; 21(11):2105-11. PubMed ID: 15587934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of fusion structure on the expression and bioactivity of human brain natriuretic peptide (BNP) albumin fusion proteins.
    Ding Y; Peng Y; Deng L; Wu Y; Fu Q; Jin J
    Curr Pharm Biotechnol; 2014; 15(9):856-63. PubMed ID: 25307015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a long-acting recombinant human serum albumin-atrial natriuretic factor (ANF) expressed in Pichia pastoris.
    de Bold MK; Sheffield WP; Martinuk A; Bhakta V; Eltringham-Smith L; de Bold AJ
    Regul Pept; 2012 Apr; 175(1-3):7-10. PubMed ID: 22296859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure.
    Chen HH; Huntley BK; Schirger JA; Cataliotti A; Burnett JC
    J Am Soc Nephrol; 2006 Oct; 17(10):2742-7. PubMed ID: 16928803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous administration of the cardiac hormone BNP in symptomatic human heart failure.
    Chen HH; Redfield MM; Nordstrom LJ; Horton DP; Burnett JC
    J Card Fail; 2004 Apr; 10(2):115-9. PubMed ID: 15101022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of brain natriuretic peptide-45, a circulating form of rat brain natriuretic peptide, in spontaneously hypertensive rats.
    Kita T; Kida O; Yokota N; Eto T; Minamino N; Kangawa K; Matsuo H; Tanaka K
    Eur J Pharmacol; 1991 Sep; 202(1):73-9. PubMed ID: 1664804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart.
    Forfia PR; Lee M; Tunin RS; Mahmud M; Champion HC; Kass DA
    J Am Coll Cardiol; 2007 Mar; 49(10):1079-88. PubMed ID: 17349888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maximizing the natriuretic peptide system in experimental heart failure: subcutaneous brain natriuretic peptide and acute vasopeptidase inhibition.
    Chen HH; Lainchbury JG; Harty GJ; Burnett JC
    Circulation; 2002 Feb; 105(8):999-1003. PubMed ID: 11864932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure.
    Fitzgerald RL; Cremo R; Gardetto N; Chiu A; Clopton P; Bhalla V; Maisel AS
    Am Heart J; 2005 Sep; 150(3):471-7. PubMed ID: 16169326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer?
    Vesely DL
    Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):169-76. PubMed ID: 16487258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Peptide Therapy With B-Type Natriuretic Peptide in Patients With Pre-Clinical Diastolic Dysfunction (Stage B Heart Failure).
    Wan SH; McKie PM; Schirger JA; Slusser JP; Hodge DO; Redfield MM; Burnett JC; Chen HH
    JACC Heart Fail; 2016 Jul; 4(7):539-547. PubMed ID: 26874387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different compartmentation of responses to brain natriuretic peptide and C-type natriuretic peptide in failing rat ventricle.
    Moltzau LR; Aronsen JM; Meier S; Skogestad J; Ørstavik Ø; Lothe GB; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Qvigstad E
    J Pharmacol Exp Ther; 2014 Sep; 350(3):681-90. PubMed ID: 25022512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANP is cleared much faster than BNP in patients with congestive heart failure.
    Kimura K; Yamaguchi Y; Horii M; Kawata H; Yamamoto H; Uemura S; Saito Y
    Eur J Clin Pharmacol; 2007 Jul; 63(7):699-702. PubMed ID: 17479256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene.
    Ogawa Y; Itoh H; Tamura N; Suga S; Yoshimasa T; Uehira M; Matsuda S; Shiono S; Nishimoto H; Nakao K
    J Clin Invest; 1994 May; 93(5):1911-21. PubMed ID: 8182124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in natriuretic peptides in congestive heart failure.
    Boerrigter G; Burnett JC
    Expert Opin Investig Drugs; 2004 Jun; 13(6):643-52. PubMed ID: 15174950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.
    Tsutamoto T; Wada A; Maeda K; Hisanaga T; Maeda Y; Fukai D; Ohnishi M; Sugimoto Y; Kinoshita M
    Circulation; 1997 Jul; 96(2):509-16. PubMed ID: 9244219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study.
    Kazanegra R; Cheng V; Garcia A; Krishnaswamy P; Gardetto N; Clopton P; Maisel A
    J Card Fail; 2001 Mar; 7(1):21-9. PubMed ID: 11264546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure.
    Davis ME; Richards AM; Nicholls MG; Yandle TG; Frampton CM; Troughton RW
    Circulation; 2006 Feb; 113(7):977-85. PubMed ID: 16476851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.